In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Aptevo Therapeutics Inc (NASDAQ: APVO) closed at $1.16 in the last session, up 4.50% from day before closing price of $1.11. In other words, the price has increased by $4.50 from its previous closing price. On the day, 0.57 million shares were traded. APVO stock price reached its highest trading level at $1.19 during the session, while it also had its lowest trading level at $1.03.
Ratios:
We take a closer look at APVO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.64 and its Current Ratio is at 2.64. In the meantime, Its Debt-to-Equity ratio is 0.44 whereas as Long-Term Debt/Eq ratio is at 0.44.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APVO now has a Market Capitalization of 4169109 and an Enterprise Value of -10206181.
Stock Price History:
Over the past 52 weeks, APVO has reached a high of $80.96, while it has fallen to a 52-week low of $0.67. The 50-Day Moving Average of the stock is -66.39%, while the 200-Day Moving Average is calculated to be -89.58%.
Shares Statistics:
According to the various share statistics, APVO traded on average about 859.68K shares per day over the past 3-months and 3715030 shares per day over the past 10 days. A total of 1.61M shares are outstanding, with a floating share count of 1.60M. Insiders hold about 0.61% of the company’s shares, while institutions hold 2.73% stake in the company. Shares short for APVO as of 1713139200 were 145614 with a Short Ratio of 0.17, compared to 1710460800 on 28856. Therefore, it implies a Short% of Shares Outstanding of 145614 and a Short% of Float of 9.090000400000001.
